MedPath

The Danish Version of the Surgical Fear Questionnaire

Completed
Conditions
Validation
Fear Anxiety
Registration Number
NCT06392698
Lead Sponsor
Gødstrup Hospital
Brief Summary

The aim of this translation and validation study is to make the The Dutch Surgical Fear Questionnaire (SFQ) applicable in adult Danish speaking patients referred to surgery.

After succesful translation of the SFQ, 200 adult patients referred to surgery at Gødstrup Hospital will be invited to answer the SFQ as well as two other questionnaires for the validation: The Pain Catastrophizing Scale (PCS) and The Hospital Anxiety and Depression Scale (HADS).

Statistical analysis will be performed to assess the correlation between the scales and thus the validity of the SFQ.

Detailed Description

Some of the instruments for assessing surgical fear are the Amsterdam Preoperative Anxiety and Information Scale (APAIS), the Hospital anxiety and depression scale (HADS), the State-Trait Anxiety Inventory (STAI) and the Visual Analog Scale assessing Anxiety (VAS-A). However, HADS, STAI and VAS-A ask questions not particular related to perioperative procedures and thus seem too generic and APAIS seems unspecific despite questions directly related to anaesthesia and the surgical procedure. The Dutch Surgical Fear Questionnaire (SFQ) was developed to be suitable for general use among all types of adult surgery patients to assess self-reported surgical fear, and to cover a broad range of short-term and long-term surgery-related fears.

The translation and validation follows the standardized multistep process outlined by Cha, Kim, and Erlen: 1) forward translation, 2) backward translation by native speakers, 3) a test of the translation in a pilot population of adults referred to surgery at Gødstrup Hospital, and 4) validation in a clinical population.

For the validation of quantitatively measured clinical variables (clinimetric validation), convergent validity will be assessed between SFQ, the Pain Catastrophizing Scale (PCS) and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). The Cronbach's alpha test will be employed to assess the internal consistency of the SFQ subscales and the overall score.

Approval of the study has been obtained from the Institutional Review Board at Central Denmark Region. Informed consent will be obtained from all participants prior to inclusion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
236
Inclusion Criteria
  • 18 years or older
  • Able to read and understand Danish
  • Cognitive well-functioning
  • No previously or ongoing diagnosed mental disorders
  • Consent to participate in the study.
Exclusion Criteria
  • Any patient who in the opinion of the investigator does not comply with the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlations between the SFQ and the PCS and SFQ and the anxiety subscale of the HADS2025

Assement will be conducted using Spearman correlation analysis

Internal consistency2025

The Cronbach's alpha test will be employed to assess the internal consistency of the SFQ

Confirmatory factor analysis2025

A confirmatory factor analysis (CFA) will be conducted to investigate whether the factor structure confirms the original Dutch version.

Cut-off values for item-specific clinically significant surgical fear2025

For each of the 8 items on the Surgical Fear Questionnaire, a cut-off value between 0-10 will be calculated to determine clinically relevant surgical fear.

Secondary Outcome Measures
NameTimeMethod
Frequency distribution2025

For each of the 8 items on the Surgical Fear Questionnaire minimum and maximum score, mean, median and Interquartile Range (IQR) will be calculated.

Floor and ceiling effect2025

Number and percentages of respondents who score the lowest value (=0) and highest value (=10) on each individual item on the Surgical Fear Questionnaire

Fear of short-term consequences of surgery2025

The first 4 items on the Surgical Fear Questionnaire constitue a subscale related to the fear of short-term consequences of surgery. Each item is rated on a numerical rating scale 0-10 where 0 is the lowest and 10 the highest level of fear. The score on the subscale ranges from 0-40.

Minimum, maximun, meand, standard deviation, median and Interquartile Range will be calculated.

Fear of long-term consequences of surgery2025

The last 4 items on the Surgical Fear Questionnaire constitute a subscale related to the fear of long-term consequences of surgery. Each item is rated on a numeric rating scale ranging from 0-10 where 0 is = not afraid and 10 = very afraid. The score on the subscale range from 0-40.

Minimum, maximum, meand, standard deviation, median and Interquartile Range will be calculated.

Scores on the Surgical Fear Questionnaire2025

The questionnaire contains 8 items and each item is rated on a numeric rating scale ranging from 0 (not afraid) to 10 (very afraid). The total score ranges from 0 to 80, where higher score means higher level of fear.

Minimum, maximum, meand, standard deviation, median and Interquartile Range will be calculated.

Scores on the Pain Catastrophizing Scale (PCS)2025

Pain Catastrophizing consists of three distinct, but interrelated concepts: rumination, magnification and helplessness which construct are assessed with three subscales on the 13-item Pain Catastrophizing Scale (PCS). Respondents provide answers on a 5-point Likert scales ranging from 0 (not at all) to 4 (all the time). Higher score indicate higher level of pain catastrophizing. The scale ranges from 0-52 Minimum, maximum, mean, standard deviation, median and Interquartile Range will be calculated.

Scores on the Hospital Depression and Anxiety Scale (HADS)2025

The HADS is commonly used in non-psychiatric hospital settings to identify anxiety disorders and depression. It comprises two subscales, Anxiety and Depression, each consisting of 7 items. Respondents provide answers on a 4-point Likert scale ranging from 0 to 3. Separate scores are computed for the Anxiety and Depression subscales, with higher scores indicating greater symptom severity. The scores range from 0-21 on each subscale.

Minimum, maximum, mean, standard deviation, median and Interquartile Range will be calculated

The association between surgical fear and gender2025

The Kruskal-Wallis test will be applied to calculated the association.

The correlation between surgical fear and age2025

The Spearman rank correlation will be applied to calculate the association.

The association between surgical fear and educational level2025

The Kruskal-Wallis test will be applied to calculate the association.

The association between surgical fear and civil status2025

The Kruskal-Wallis test will be applied to calculate the association.

The association between surgical fear and type of admission (day surgery versus hospitalised overnight)2025

The Mann-Whitney U Test will be applied to calculate the association

The association between surgical fear and cancer versus non-cancer surgery2025

The Kruskal-Wallis test will be applied to calculate the association

The association between surgical fear and previous surgery versus no previous surgery2025

The Mann-Whitney U Test will be applied to calculate the association.

The association between surgical fear and type of anaesthesia2025

Three groups of anaesthesia:

1. General alone, vs

2. General plus regional with or without sedation vs

3. Regional or local with or without sedation The Kruskal-Wallis Test will be applied for the calculations. In case of significant results the test will be followed by Dunn's test with Bonferroni correction to determine which specific groups are different.

The association between surgical fear and postoperative pain2025

A logistic regression analysis will be applied to calculate the likelihood of postoperative pain score based on preoperative surgical fear.

Trial Locations

Locations (1)

Gødstrup Hospital

🇩🇰

Herning, Denmark

Gødstrup Hospital
🇩🇰Herning, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.